Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
PDA Journal of Pharmaceutical Science and Technology
  • .
    • Visit PDA
    • PDA Letter
    • Technical Reports
    • news uPDATe
    • Bookstore
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
PDA Journal of Pharmaceutical Science and Technology

Advanced Search

  • Home
  • Content
    • Current Issue
    • Past Issues
    • Accepted Articles
    • Email Alerts
    • RSS
    • Terms of Use
  • About PDA JPST
    • JPST Editors and Editorial Board
    • About/Vision/Mission
    • Paper of the Year
  • Author & Reviewer Resources
    • Author Resources / Submit
    • Reviewer Resources
  • JPST Access and Subscriptions
    • PDA Members
    • Institutional Subscriptions
    • Nonmember Access
  • Support
    • Join PDA
    • Contact
    • Feedback
    • Advertising
    • CiteTrack
  • Follow pda on Twitter
  • Visit PDA on LinkedIn
  • Visit pda on Facebook
Article CommentaryCommentary

Principles for Management of Extractables and Leachables in Ophthalmic Drug Products

Christopher T. Houston, Andrea Desantis Rodrigues, Brenda Birkestrand Smith, Tao Wang and Mary Richardson
PDA Journal of Pharmaceutical Science and Technology May 2022, 76 (3) 278-294; DOI: https://doi.org/10.5731/pdajpst.2022.012744
Christopher T. Houston
1Bausch & Lomb, 1400 North Goodman St., Rochester, NY 14609;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: christopher.houston@bausch.com
Andrea Desantis Rodrigues
2PYC Therapeutics, 3210 Merryfield Row, San Diego, CA 92121;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brenda Birkestrand Smith
3Vir Biotechnology, 499 Illinois St., San Francisco, CA 94158;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Wang
4AbbVie, 2525 Dupont Drive, Irvine, CA 92612; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Richardson
5iuvo BioScience, 7500 West Henrietta Rd, Rush, NY 14543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 76 no. 3 278-294
DOI 
https://doi.org/10.5731/pdajpst.2022.012744
PubMed 
35169039

Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Published online June 1, 2022.

Article Versions

  • previous version (February 15, 2022 - 08:07).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© PDA, Inc. 2022

Author Information

  1. Christopher T. Houston1,*,
  2. Andrea Desantis Rodrigues2,
  3. Brenda Birkestrand Smith3,
  4. Tao Wang4 and
  5. Mary Richardson5
  1. 1Bausch & Lomb, 1400 North Goodman St., Rochester, NY 14609;
  2. 2PYC Therapeutics, 3210 Merryfield Row, San Diego, CA 92121;
  3. 3Vir Biotechnology, 499 Illinois St., San Francisco, CA 94158;
  4. 4AbbVie, 2525 Dupont Drive, Irvine, CA 92612; and
  5. 5iuvo BioScience, 7500 West Henrietta Rd, Rush, NY 14543
  1. ↵*Corresponding Author: Bausch & Lomb, 1400 North Goodman St., Rochester, NY 14609; Telephone: (585) 338-6764; E-mail: christopher.houston{at}bausch.com
View Full Text

Cited By...

  • 5 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Physico-Chemical Aspects of Dosage Forms and Biopharmaceutics
    Tanima Sarkar, Shalmoli Seth, Bibek Laha
    2024
  • Advances in Pharmaceutical Product Development
    Ankita Kishore, Neeraj Mishra, Jovita Kanoujia, Prem Prakash Singh, Alok Kumar Mahor
    2025
  • Considerations and derivations of permitted daily exposure limits for impurities from intravitreal pharmaceutical products
    Yi Yu Rice, David G. Dolan, Suren B. Bandara, Ryan E. Morgan, Michael Garry, Joyce Tsuji
    Regulatory Toxicology and Pharmacology 2025 155
  • Specification of Drug Substances and Products
    James R. Scull, Michael Ruberto, Kurt L. Moyer
    2025
  • Specification of Drug Substances and Products
    Huahua Jian, Tao Wang, Chetan Pujara
    2025
PreviousNext
Back to top

In This Issue

PDA Journal of Pharmaceutical Science and Technology: 76 (3)
PDA Journal of Pharmaceutical Science and Technology
Vol. 76, Issue 3
May/June 2022
  • Table of Contents
  • Index by Author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on PDA Journal of Pharmaceutical Science and Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Principles for Management of Extractables and Leachables in Ophthalmic Drug Products
(Your Name) has sent you a message from PDA Journal of Pharmaceutical Science and Technology
(Your Name) thought you would like to see the PDA Journal of Pharmaceutical Science and Technology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 3 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Principles for Management of Extractables and Leachables in Ophthalmic Drug Products
Christopher T. Houston, Andrea Desantis Rodrigues, Brenda Birkestrand Smith, Tao Wang, Mary Richardson
PDA Journal of Pharmaceutical Science and Technology May 2022, 76 (3) 278-294; DOI: 10.5731/pdajpst.2022.012744

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Principles for Management of Extractables and Leachables in Ophthalmic Drug Products
Christopher T. Houston, Andrea Desantis Rodrigues, Brenda Birkestrand Smith, Tao Wang, Mary Richardson
PDA Journal of Pharmaceutical Science and Technology May 2022, 76 (3) 278-294; DOI: 10.5731/pdajpst.2022.012744
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Background
    • Importance of Assessing Leachables in ODPs
    • Current Regulatory Approaches
    • Specific Considerations for Managing Leachables in ODPs
    • Potential Sources and Common Classes of Leachables for ODPs
    • False Negatives Observed during Extractable Testing of Secondary Packaging Components and Leachable Testing of Drug Products for Which Secondary Packaging Components Are Critical
    • Experimental Design Considerations: Extraction/Simulation Studies for ODPs
    • Experimental Design Considerations: Leachable Studies for ODPs
    • Analytical Evaluation Threshold
    • Summary of Analytical Challenges for Extractables and Leachables in ODPs
    • Toxicological Considerations for Leachables in ODPs
    • Safety Qualification for Leachables in ODPs
    • Conclusion: Toxicological Considerations for Leachables in ODPs
    • Case Study on the Safety Qualification of Leachables in an ODP
    • General Sample Evaluation (with Examples of Assessment Tables)
    • Conclusion: Case Study
    • Conflict of Interest Declaration
    • Acknowledgment
    • Footnotes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Retrospective Evaluation of Cycled Resin in Viral Clearance Studies - A Multiple Company Collaboration - Post ICH Q5A(R2) Review
  • Addressing Medical Device Extractables and Leachables via Non-Target Analysis (NTA); The Analytical Evaluation Threshold (AET) and Quantitation
  • Expanding the Use of Moist Heat for Terminal Sterilization
Show more Commentary

Similar Articles

Keywords

  • Extractables
  • Leachables
  • Ophthalmics
  • Toxicity
  • Endpoints
  • Migrant
  • Simulation

Readers

  • About
  • Table of Content Alerts/Other Alerts
  • Subscriptions
  • Terms of Use
  • Contact Editors

Author/Reviewer Information

  • Author Resources
  • Submit Manuscript
  • Reviewers
  • Contact Editors

Parenteral Drug Association, Inc.

  • About
  • Advertising/Sponsorships
  • Events
  • PDA Bookstore
  • Press Releases

© 2025 PDA Journal of Pharmaceutical Science and Technology Print ISSN: 1079-7440  Digital ISSN: 1948-2124

Powered by HighWire